Contrôles Essais Mesures
Monday, August 8, 2022
  • Find out!
  • Receive our newsletter
  • Contact us
  • English
  • Français
  • Articles
    • Measures
    • Non destructive testing
    • Optical
    • Automatisms
    • Industrial data
    • Management
    • Type d’info
      • Market Info
      • Product Info
  • Expert opinions
  • Agenda
  • Spotlight
  • Podcasts
    • Metrolaudio
    • Questions de métrologie
    • 3 questions for ...
    • Editos
  • Kit media
No result
See all results
  • Articles
    • Measures
    • Non destructive testing
    • Optical
    • Automatisms
    • Industrial data
    • Management
    • Type d’info
      • Market Info
      • Product Info
  • Expert opinions
  • Agenda
  • Spotlight
  • Podcasts
    • Metrolaudio
    • Questions de métrologie
    • 3 questions for ...
    • Editos
  • Kit media
No result
See all results
Contrôles Essais Mesures
No result
See all results
Home Non destructive testing

AI for a more objective skin analysis

By Contrôles Essais Mesures
12 October 2021
in Non destructive testing
Reading time: 3 min
Share on LinkedInShare on FacebookShare on twitter

Archos announces the creation of Poladerme, currently 40% owned by Medical Devices Venture1,a subsidiary of Archos whose objective is to develop a portfolio of stakes in the field of new health technologies.

The ambition of the startup Poladerme is to become a leader in spectropolarimetry combined with artificial intelligence and machine learning, applied to dermatology.

The company Poladerme, matured by Conectus, the Satt (Société d'accélération du transfert de technologies) of Strasbourg, is developing an innovative, fast and non-invasive diagnostic aid solution, based on an optical system and artificial intelligence algorithms to deeply analyze tissues and assess the state of health of the skin2.

A company born of research

In the ICube laboratory at the University of Strasbourg, France, Professors Jihad Zallat and Christian Heinrich have been conducting research on spectropolarimetry and image processing and analysis techniques for more than 10 years in the Trio and Images research teams. The biomedical field is the preferred application framework.

The two researchers collaborated closely with partners biologists, doctors and dermatology researchers, including strong interactions with Inserm and the dermatology department of the University Hospitals of Strasbourg. With a scientific relevance validated by publications and based on a clinical study3, and the achievement of a point of maturity to transfer this approach into a medical device, Medical Devices Venture participated in the creation of the company Poladerme to support it in the industrialization and commercialization of its solution.

Cutting-edge technology at the service of dermatology

The skin occupies a fundamental place in the health and well-being of body and mind. Indeed the skin, the largest organ of the body, is the revealer of many diseases and is prone to premature aging.

The dermatoscope, a skin analysis tool used today, is based on the magnifying glass, a technology that dates back to the 11th century.

Poladerme demonstrates that skin analysis will involve a new technology, namely spectropolarimetry and artificial intelligence algorithms. A source of significant improvement in the daily lives of healthcare professionals and patients, this new technology will allow, through its wide dissemination, a reduction in analysis times as well as a more objective reading, thus reducing the field left to interpretation, richer and deeper lesions.

Spectropolarimetry is a very promising modality for the detection and diagnosis of cancer. A contrast between healthy and diseased tissues has been found in a wide variety of human organs. Polarization is a powerful tool because it allows you to explore various aspects of tissue organization. It is sensitive to birefringent structures such as collagen and muscle fibers, myelin and keratin, as well as to disruptions in tissue structure via depolarization. Then, using global statistical models based on decision theory, the Poladerme system will propose a classification of the sample associated with a confidence level.

The Poladerme solution will be available in the first half of 2022.

1 It is stated that under the terms of an investment protocol concluded between Poladerme's partners on 9 September 2021, Medical Devices Venture will hold 53.3% of Poladerme's capital following a capital increase to be carried out by 31 December 2021 at the latest.
2 The technology developed by the researchers is granted to Poladerme by Satt Conectus under an exclusive licence.
3 Finalized clinical study scheduled for publication in early 2022

For more information:
www.archos.com

Labels: Product Info
Previous article

Artificial Intelligence Evaluation Forum

Next article

Trescal acquires Broadview Instrumentation Services and the calibration business of Sudel Industries

Related articles

Non destructive testing

Cofrend Days 2023, the great gathering of the entire NDT sector

The countdown is on for the next major event of the Cofrend National Congress, a unique event that brings together all industrial sectors around the same theme:...

By Contrôles Essais Mesures
July 29, 2022
Non destructive testing

Automated quality control using collaborative robots: a game changer for small and medium-sized businesses

In order to facilitate access to automation, Creaform unveils the latest version of its VXscan-R software module, which includes innovative features, guaranteed to offer the best operational flexibility and...

By Writing
June 27, 2022
Non destructive testing

Artec 3D lance Artec Studio 17

Artec 3D, a world-renowned developer and manufacturer of professional 3D scanners and software, today announced the release of Artec Studio 17 (AS17), the new version of its scanning software...

By Writing
June 23, 2022
Non destructive testing

TraiNDE RT v1.1, a new tool for training Radio operators

Extende is proud to announce the availability of TraiNDE RT version 1.1, the simulator for training END operators in radiography. With this new version, operators now have access to...

By Writing
June 21, 2022
Non destructive testing

Francia confirms its place in the 4.0 factory by equipping itself with the new Zeiss Metrotom 1 X-ray tomograph!

In a desire to continuously improve the quality requirements of its products, the French plastic injection company Francia, located in Bellignat (01), has acquired the latest Zeiss X-ray technology...

By Writing
June 8, 2022
Non destructive testing

Raised Stopper Inspection, a solution for detecting industrial errors in vial capping in a sterile environment

The only solution on the market dedicated to the inspection of freeze-dried bottles in a sterile environment, the Raised Stopper Inspection (RSI) is equipped with a high-performance camera system and manages the area of...

By Writing
June 3, 2022
Next article

Trescal acquires Broadview Instrumentation Services and the calibration business of Sudel Industries

Our latest issue

For more feature articles, subscribe to Contrôles Essais Mesures magazine.

Spotlight

Advertising

Newsletter

Receive free information from the Contrôles Essais Mesures website with each publication

You can unsubscribe at any time. Your data is processed according to our privacy policy.

Thank you !

Please now check your inbox or junk folder to confirm your subscription.

.

Our partners

Contrôles Essais Mesures

© 2021 Contrôles Essais Mesures, the technology and application review for laboratories and industry.

You want ?

  • Contact
  • Who are we ?
  • Become an advertiser
  • Sitemap
  • Legal Notice
  • Data protection
  • Unsubscribe from the newsletter

Follow us

No result
See all results
  • Item categories
    • Measures
    • Non destructive testing
    • Optical
    • Automatisms
    • Management
  • Expert opinions
  • Magazine
    • Presentation
    • Kit media 2021
  • Agenda
  • Spotlight
  • Podcasts
    • Metrolaudio
    • Questions de métrologie
    • 3 questions for ...
    • Editos
  • Contact
  • English
  • Français

© 2021 Contrôles Essais Mesures, the technology and application review for laboratories and industry.

Ce site utilise des cookies. Vous pouvez visiter notre politique de protection ds données personnelles pour en savoir plus.
X